MYLAN SM 12.5 MYLAN SM 12.5 Pill: brown, capsule/oblong, 14mm
The pill with imprint MYLAN SM 12.5 MYLAN SM 12.5 (Brown, Capsule/Oblong, 14mm) has been identified as Sunitinib Malate 12.5 mg and is used for Renal Cell Carcinoma, Gastrointestinal Stromal Tumor, and Pancreatic Cancer. It belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors and is not a controlled substance.
Images for MYLAN SM 12.5 MYLAN SM 12.5
Sunitinib Malate
- Imprint
- MYLAN SM 12.5 MYLAN SM 12.5
- Strength
- 12.5 mg
- Color
- Brown
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-6678
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
gelatin,
magnesium stearate,
mannitol,
sodium lauryl sulfate,
titanium dioxide,
ferric oxide red,
ammonia,
ferrosoferric oxide,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
Related images for "MYLAN SM 12.5 MYLAN SM 12.5"
More about sunitinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (35)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.